Literature DB >> 20231687

Peripheral B cell tolerance and function in transgenic mice expressing an IgD superantigen.

Bao Hoa Duong1, Takayuki Ota, Djemel Aït-Azzouzene, Miyo Aoki-Ota, José Luis Vela, Christoph Huber, Kevin Walsh, Amanda L Gavin, David Nemazee.   

Abstract

Transitional B cells turn over rapidly in vivo and are sensitive to apoptosis upon BCR ligation in vitro. However, little direct evidence addresses their tolerance sensitivity in vivo. A key marker used to distinguish these cells is IgD, which, through alternative RNA splicing of H chain transcripts, begins to be coexpressed with IgM at this stage. IgD is also expressed at high levels on naive follicular (B-2) and at lower levels on marginal zone and B-1 B cells. In this study, mice were generated to ubiquitously express a membrane-bound IgD-superantigen. These mice supported virtually no B-2 development, a greatly reduced marginal zone B cell population, but a relatively normal B-1 compartment. B cell development in the spleen abruptly halted at the transitional B cell population 1 to 2 stage, a block that could not be rescued by either Bcl-2 or BAFF overexpression. The developmentally arrested B cells appeared less mature and turned over more rapidly than nontransgenic T2 cells, exhibiting neither conventional features of anergy nor appreciable receptor editing. Paradoxically, type-2 T-independent responses were more robust in the transgenic mice, although T-dependent responses were reduced and had skewed IgL and IgH isotype usages. Nevertheless, an augmented memory response to secondary challenge was evident. The transgenic mice also had increased serum IgM, but diminished IgG, levels mirrored by the increased numbers of IgM(+) plasma cells. This model should facilitate studies of peripheral B cell tolerance, with the advantages of allowing analysis of polyclonal populations, and of B cells naturally lacking IgD.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20231687      PMCID: PMC2874719          DOI: 10.4049/jimmunol.0903564

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  120 in total

1.  Negative selection of immature B cells by receptor editing or deletion is determined by site of antigen encounter.

Authors:  P C Sandel; J G Monroe
Journal:  Immunity       Date:  1999-03       Impact factor: 31.745

2.  Characterization of anergic anti-DNA B cells: B cell anergy is a T cell-independent and potentially reversible process.

Authors:  H Noorchashm; A Bui; H L Li; A Eaton; L Mandik-Nayak; C Sokol; K M Potts; E Puré; J Erikson
Journal:  Int Immunol       Date:  1999-05       Impact factor: 4.823

3.  Developmental regulation of B lymphocyte immune tolerance compartmentalizes clonal selection from receptor selection.

Authors:  D Melamed; R J Benschop; J C Cambier; D Nemazee
Journal:  Cell       Date:  1998-01-23       Impact factor: 41.582

Review 4.  The "clonal selection hypothesis" and current concepts of B cell tolerance.

Authors:  N R Klinman
Journal:  Immunity       Date:  1996-09       Impact factor: 31.745

5.  BCR ligation induces receptor editing in IgM+IgD- bone marrow B cells in vitro.

Authors:  M Hertz; D Nemazee
Journal:  Immunity       Date:  1997-04       Impact factor: 31.745

6.  Regulation of IgM and IgD heavy chain gene expression: effect of abrogation of intergenic transcriptional termination.

Authors:  D Yuan; P L Witte; J Tan; J Hawley; T Dang
Journal:  J Immunol       Date:  1996-09-01       Impact factor: 5.422

7.  A novel chimeric Ig heavy chain from a teleost fish shares similarities to IgD.

Authors:  M Wilson; E Bengtén; N W Miller; L W Clem; L Du Pasquier; G W Warr
Journal:  Proc Natl Acad Sci U S A       Date:  1997-04-29       Impact factor: 11.205

8.  Characterization of immature B cells by a novel monoclonal antibody, by turnover and by mitogen reactivity.

Authors:  A G Rolink; J Andersson; F Melchers
Journal:  Eur J Immunol       Date:  1998-11       Impact factor: 5.532

9.  IgD can largely substitute for loss of IgM function in B cells.

Authors:  C Lutz; B Ledermann; M H Kosco-Vilbois; A F Ochsenbein; R M Zinkernagel; G Köhler; F Brombacher
Journal:  Nature       Date:  1998-06-25       Impact factor: 49.962

10.  Enforced Bcl-2 expression inhibits antigen-mediated clonal elimination of peripheral B cells in an antigen dose-dependent manner and promotes receptor editing in autoreactive, immature B cells.

Authors:  J Lang; B Arnold; G Hammerling; A W Harris; S Korsmeyer; D Russell; A Strasser; D Nemazee
Journal:  J Exp Med       Date:  1997-11-03       Impact factor: 14.307

View more
  12 in total

1.  Transplantation tolerance modifies donor-specific B cell fate to suppress de novo alloreactive B cells.

Authors:  Stella Hw Khiew; Dharmendra Jain; Jianjun Chen; Jinghui Yang; Dengping Yin; James S Young; Alexander Dent; Roger Sciammas; Maria-Luisa Alegre; Anita S Chong
Journal:  J Clin Invest       Date:  2020-07-01       Impact factor: 14.808

Review 2.  The function and regulation of immunoglobulin D.

Authors:  Kang Chen; Andrea Cerutti
Journal:  Curr Opin Immunol       Date:  2011-02-24       Impact factor: 7.486

3.  Negative selection by IgM superantigen defines a B cell central tolerance compartment and reveals mutations allowing escape.

Authors:  Bao Hoa Duong; Takayuki Ota; Miyo Aoki-Ota; Anthony Byron Cooper; Djemel Ait-Azzouzene; José Luis Vela; Amanda Lee Gavin; David Nemazee
Journal:  J Immunol       Date:  2011-10-31       Impact factor: 5.422

4.  Deletion of IgG-switched autoreactive B cells and defects in Fas(lpr) lupus mice.

Authors:  Djemel Aït-Azzouzene; Dwight H Kono; Rosana Gonzalez-Quintial; Louise J McHeyzer-Williams; Min Lim; Dilki Wickramarachchi; Tobias Gerdes; Amanda L Gavin; Patrick Skog; Michael G McHeyzer-Williams; David Nemazee; Argyrios N Theofilopoulos
Journal:  J Immunol       Date:  2010-06-16       Impact factor: 5.422

5.  Analyses of recombinant stereotypic IGHV3-21-encoded antibodies expressed in chronic lymphocytic leukemia.

Authors:  Emanuela M Ghia; George F Widhopf; Laura Z Rassenti; Thomas J Kipps
Journal:  J Immunol       Date:  2011-04-27       Impact factor: 5.422

6.  Regulation of basement membrane-reactive B cells in BXSB, (NZBxNZW)F1, NZB, and MRL/lpr lupus mice.

Authors:  Amy G Clark; Qihua Fan; Graham F Brady; Katherine M Mackin; Evan D Coffman; Melissa L Weston; Mary H Foster
Journal:  Autoimmunity       Date:  2013-01-09       Impact factor: 2.815

7.  Functionally responsive self-reactive B cells of low affinity express reduced levels of surface IgM.

Authors:  Greg A Kirchenbaum; James B St Clair; Thiago Detanico; Katja Aviszus; Lawrence J Wysocki
Journal:  Eur J Immunol       Date:  2014-01-20       Impact factor: 5.532

8.  Liver-expressed Igkappa superantigen induces tolerance of polyclonal B cells by clonal deletion not kappa to lambda receptor editing.

Authors:  Takayuki Ota; Miyo Ota; Bao Hoa Duong; Amanda L Gavin; David Nemazee
Journal:  J Exp Med       Date:  2011-02-28       Impact factor: 14.307

Review 9.  Harnessing Newton's third-law paradigm to treat autoimmune diseases and chronic inflammations.

Authors:  Tue Gia Nguyen
Journal:  Inflamm Res       Date:  2020-06-26       Impact factor: 6.986

10.  Global analysis of B cell selection using an immunoglobulin light chain-mediated model of autoreactivity.

Authors:  Sarah F Andrews; Qingzhao Zhang; Samuel Lim; Lie Li; Jane-Hwei Lee; Nai-Ying Zheng; Min Huang; William M Taylor; A Darise Farris; Dongyao Ni; Wenzhao Meng; Eline T Luning Prak; Patrick C Wilson
Journal:  J Exp Med       Date:  2012-12-24       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.